Skip to main content
Equibles
SUPN $48.27 +2.38%
SUPN logo

SUPN · Supernus Pharmaceuticals, Inc.

Track SUPN — free

Use SUPN with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about SUPN

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$48.27 +1.12 (+2.38%) At close · Aug 14
Market Cap
$2.81B
Shares
58.13M
All earnings calls

Earnings call · FY2023 Q4

Supernus Pharmaceuticals, Inc. Q4 FY2023 Earnings Call

Supernus Pharmaceuticals, Inc. Q4 FY2023 Earnings Call

Concluded Feb 27, 2024
Feb 27, 2024 0 turns
Period
FY2023 Q4
Runtime
—
Sources
2 artifacts
8-K 10-K

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

Research coverage

2 live sources

Switch sources without leaving this page or losing your listening position.

Revenue · derived Q4 $164.31M -1.8% YoY
Net income · derived Q4 $1.18M -95.4% YoY

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Feb 27, 2024 10-K report Filed Feb 27, 2024
Full-screen source Call document

Report a Problem

Category
Description
Email (optional, for follow-up)